Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
Anti-CD19 CAR-T for R/R CLL: How Frequent Are MRD- Responses? When Do Relapses Happen? How Many Patients Can Achieve CR?
Comments 0
Login to view comments.
Click here to Login